Candel Therapeutics
CADL
CADL
80 hedge funds and large institutions have $116M invested in Candel Therapeutics in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less capital invested
Capital invested by funds: $117M → $116M (-$1.03M)
4.72% less ownership
Funds ownership: 45.98% → 41.27% (-4.7%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
80
Holding in Top 10
1
Calls
$2.96M
Puts
$717K
Top Buyers
| 1 | +$1.29M | |
| 2 | +$1.12M | |
| 3 | +$697K | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$598K |
| 5 |
Kovitz Investment Group Partners
Chicago,
Illinois
|
+$405K |
Top Sellers
| 1 | -$1.8M | |
| 2 | -$1.21M | |
| 3 | -$1.19M | |
| 4 |
Renaissance Technologies
New York
|
-$828K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$660K |
